Optibiotix Health Share Discussion Threads

[scotty1] 20/4/2017 08:18

Nice to see you bought a abacus and playing nicely someuwin ;)))

[someuwin] 20/4/2017 08:12

Only two more full trading days until Results and full update.

(I'm adding)

[bernieboy] 20/4/2017 08:09

Risky all true except the listing in 2017. Was 2014 of course - I know you know that - probably just a typo......

[parob] 20/4/2017 07:34

I'm expecting a scramble for cheap stock today...

[john henry] 20/4/2017 07:30

JJ IMHO a large seller has been responsible for the recent tumble from the high eighties. Probably YSF. If they have completed then share price should recover.

[judijudi] 20/4/2017 07:08

Hoping for a bounce today
Odd that we are so much closer to the 60's than the 80's with all that has happened lately, and what is to come shortly

[riskybusiness1] 20/4/2017 00:21

My point is that following reaching 1£ opti retraced and stabilised around 80p for many months until the market realised it was too early for revenues and products....the amount of positive news announced since, especially recently has hugely increased the growth prospects of this company.Opti is an early stage company, founded in 2012, listed in 2017.Opti is using the exact same science as 4d pharma, using it in a way that still targets massive markets but different markets and because of this is able to do this at a fraction of the cost. Opti must be min 5+ years ahead of 4d in terms of generating revenues. 4d has no commercial deals/partners in place for future revenues, has huge operating costs, huge risks still as working through multiple regulations and also the woodfood fund has lost a great deal of respect in the city (woodfoods following probably one of the main reasons behind 4ds previous ridiculous £500m valuation) it's completely understandable why 4d has dropped off.Opti on the other hand launched go figure (slimbiome) early, not for huge revenues, but still revenues and used the soft launch to test slimbiomes viability in the market. Now has a deal with tata because of it. Launching next month lpldl (cholbiome and cardibiime) and slimbiome at vitafoods, a major event for this industry. It shows research and development now clearly turning to commercialisation.......The hardest and riskiest part to a business like opti is the ability to successfully develop the intellectual property in to viable products. It will take time to build revenues but 80-100k pretty much fixed costs business with these types of products now coming to market should grow very rapid and consistently. Who's not going to buy a cholesterol reducing ingredient independently tested to reduce both blood pressure and cholesterol (no product on the market does this and is a huge usp)

[incanus] 19/4/2017 23:42

22370 i think i have just trickled.

[parsnip1] 19/4/2017 23:36

With you Elrico. The perceived value diminishing as of today versus the net contribution is where confusion lie. Some bright poster has already highlighted that games are being played. I can assure those who are interested that neither the company nor it's advisors are party to any gamesmanship. Am in standby mode for some elasticity in the price but will settle for happiness and extreme contentment by Christmas. I'll leave the board to vilify me at will. Over and out

[elrico] 19/4/2017 23:24

Parsnip my old manc muca - the surprise and confusion perhaps relates to the irrational nature of turning £660k into £6M @ 42%. Since the IPO OPTI has lost 15% of its market value, EQUAL TO £12m. I don't mind confessing I'm bloody confused, BUT VERY pleased I appear to have got my wish. Tongue in cheek I asked peeps not to buy anymore until my modest funds cleared :)

I would add, we don't know when the SBTX shares will be divested to shareholders and under what conditions. They will almost certainly have lock-in periods so they are not flipped.

IMHO we have witnessed another MM manipulation akin to when you bought your 111,111 on the 17th March. Mugs punters were walked down to stops to fill your order, which I think represented c60% of the volume that day. Everyone assumed it must be a sell. Of course you and I knew differently.

[parsnip1] 19/4/2017 23:01

The company is probably about to share/ divest £8m of value amongst the shareholders. Give or take 12% of the market cap. If it doesn't happen it is at least what the market believes. Not sure why the surprise and/or confusion

[trotterstrading] 19/4/2017 22:14

Added a few more on the dip this afternoon. I've been here since IPO, seen it all since then, ups, downs, and treading water. The key point is that the company has continued to make strong progress across it entire product range over the past 24 months. Short term share price fluctuations are not important, the 'market' is an imperfect mechanism and At current levels I'm confident OPTI is in oversold territory and significantly undervalued. Strong buy for me

[nicktopten] 19/4/2017 21:47

Its the business model of Probi that is similar to Opti.... not the time frame for any share price increase!!!!!
If Opti were a one trick pony, like a lot out there, you might get a bit worried about a decline in price (people knowing some bad news that you don't), but its not. There are multiple revenue streams in multiple markets for this one, and therefore the risk is spread.
My personal view is that Opti will at some point in the next 12 months have a huge uplift in its share price.... this not based on my natural optimism, but an understanding of Opti model, science and what is being put in place now.

[lukead] 19/4/2017 20:22

And why are you here Bran when you are telling people to sell. Why is SOH equating OPTI to PROBI (you say it 10years to take off) if they are in different sectors.

[judijudi] 19/4/2017 20:11

Bran,
Since when have Opti been a Biotech?

[parob] 19/4/2017 19:58

So far the only revenue we've received from product sales has been from GoFigure, and whilst successful, it hasn't been mass market.The cardio products will be a different ball game altogether and our partners will have their own PR and marketing spend to promote the products. They will be targeting the mass market. As has been said time and time again, there is nothing else like it on the market currently.The cardio products will be the game changer here IMO and we now have less than 3 weeks to wait!

[bobdown2] 19/4/2017 19:52

It's not a biotech...check the sector it comes under..healthcare. It does not need to go through 3 stages of clinical trials that takes years. The time to market is so quick it is happening already!

[branboyd1] 19/4/2017 19:50

I stand corrected about Probi. Looking at the share price trajectory it took 10 years to multibag.

[branboyd1] 19/4/2017 19:47

lukead, Probi took five years to take off so we may have a wait yet. Steven Ohara has repeatedly stated in the last few weeks that Opti is at the very early stage. I'm certain this will reach £1.50 but when? Could be years away. If you are prepared to be patient you will be rewarded here because it's going to take time to build up the asset value here, I think everyone on this board wants quick news and quick share price reaction. If so, you're in the wrong share. Biotech will take its time like Opti is doing so and fluctuations in the share price are par for the course. Sell and buy something that could rocket in a year, this is going to be a very slow burner.

[septimus quaid] 19/4/2017 19:47

Down 24% on these, damn the UK Investor show.

Jus goes to show that the "experts" are as clueless as the rest of us.

Luckily, I've only a relatively small amount invested.

[marnewton] 19/4/2017 19:42

lukead,

I'm not hedging my bets 'now'. Charts are by their very nature equivocal. I tried to make that plain in my analysis. As I said before, you have to read the whole thing.

And, of course, since I posted on that snapshot in time, the world has changed somewhat. Maybe more macro than micro?

Certainly investors have become more risk averse and market makers have used that to their advantage to ramp up volume (income).

M

[lukead] 19/4/2017 19:38

Re above agree on the whole, but you can not just say "and OPTI was 100 before all this, " just look at DDDD, I don't know much about it, but was it not £9 at one time, maybe it has issued poor news since those dizzy highs. Point is, just because a share got to ? did not necessarily mean it deserved to be rated at ? I wonder when PROBI took off ? As SOH generally equates to that company.

[parob] 19/4/2017 19:36

I bet there'll be some fingers ready to hit the buy button tomorrow morning, with folk amazed they've been given the chance to buy at this price at this stage in the game.